Susquehanna International Group, LLP Neuro Bo Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.4 - $0.9 $38,711 - $87,101
96,779 Added 822.81%
108,541 $51,000
Q2 2021

Aug 11, 2021
SELL
$2.74 - $4.63 $31,994 - $54,064
-11,677 Reduced 49.82%
11,762 $39,000
Q1 2021

May 17, 2021
BUY
$3.93 - $6.68 $92,115 - $156,572
23,439 New
23,439 $103,000

About NeuroBo Pharmaceuticals, Inc.

NRBO Quotes by TradingView
  • Ticker NRBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 888,693
  • Market Cap $2.13M
  • Description
  • NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...
More about NRBO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email